D. Hopkins

发表

Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?

M. Nieuwdorp, J. Devière, F. Holleman, 2021, Gut.

COVID-19 and metabolic disease: mechanisms and clinical management

K. Khunti, F. Rubino, J. Chan, 2021, The Lancet Diabetes & Endocrinology.

Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes

P. Shah, A. Lahiri, J. Nilsson, 2009, Diabetologia.

Associations between autoantibodies against apo B100 peptides and vascular complications in patients with type 2 diabetes

P. Shah, A. Lahiri, J. Nilsson, 2009 .

Consequences of the COVID-19 pandemic for patients with metabolic diseases

K. Khunti, F. Rubino, J. Chan, 2021, Nature Metabolism.

Endocrine and metabolic link to coronavirus infection

B. Boehm, S. Bornstein, G. Mingrone, 2020, Nature Reviews Endocrinology.

Durable Metabolic Improvements 2 Years After Duodenal Mucosal Resurfacing (DMR) in Patients With Type 2 Diabetes (REVITA-1 Study).

R. Haidry, M. Nieuwdorp, G. Costamagna, 2022, Diabetes research and clinical practice.

New-Onset Diabetes in Covid-19

K. Khunti, F. Rubino, R. Eckel, 2020, The New England journal of medicine.

The effect of COVID-19 on routine diabetes care and mortality in people with diabetes

F. Rubino, D. Hopkins, 2022, The Lancet Diabetes & Endocrinology.

African Caribbean Ethnicity Is an Independent Predictor of Significant Decline in Kidney Function in People With Type 1 Diabetes.

N. Fountoulakis, S. Ayis, L. Gnudi, 2022, Diabetes care.

The role of preoperative vitamin D and calcium in preventing post-thyroidectomy hypocalcaemia: a systematic review.

D. Hopkins, Cian Casey, 2022, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery.

Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery

F. Rubino, R. Eckel, P. Schauer, 2020, The Lancet Diabetes & Endocrinology.

Practical recommendations for the management of diabetes in patients with COVID-19

Geltrude Mingrone, Kamlesh Khunti, Eric Renard, 2020, The Lancet Diabetes & Endocrinology.

Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study

J. Tijssen, R. Haidry, M. Nieuwdorp, 2019, Gut.

High levels of IgM against methylglyoxal‐modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes

P. Shah, A. Lahiri, J. Nilsson, 2012, Journal of internal medicine.

Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers.

D. Lipkin, P. Bassett, A. Lahiri, 2007, Journal of the American College of Cardiology.

The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.

A. Lahiri, D. V. Anand, E. Lim, 2006, Journal of the American College of Cardiology.

Relationship Between Plasma steoprotegerin Levels and Coronary Artery alcification in Uncomplicated Type 2 Diabetic Subjects

A. Lahiri, D. Hopkins, Hitesh Anand, 2006 .

Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy.

L. Shaw, D. Lipkin, P. Sharp, 2006, European heart journal.

People With Type 1 Diabetes of African Caribbean Ethnicity Are at Increased Risk of Developing Sight-Threatening Diabetic Retinopathy

N. Fountoulakis, S. Ayis, L. Webster, 2023, Diabetes care.

The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?

T. Chowdhury, P. Dodson, G. Vafidis, 2002, Eye.

Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial

Deepak L. Bhatt, R. Haidry, G. Costamagna, 2021, Gut.

Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes, challenging the diagnostic threshold of diabetes

C. Bergeles, R. Malik, Timothy L. Jackson, 2021, Diabetic medicine : a journal of the British Diabetic Association.

ASSOCIATIONS BETWEEN DYSGLYCEMIA, RETINAL NEURODEGENERATION, AND MICROALBUMINURIA IN PREDIABETES AND TYPE 2 DIABETES

Timothy L. Jackson, V. Kirthi, U. Alam, 2021, Retina.

Practical recommendations for the management of diabetes in patients with COVID-19.

K. Khunti, F. Rubino, J. Chan, 2020, The Lancet Diabetes and Endocrinology.

Intra‐abdominal hypertension and the abdominal compartment syndrome

L. Gemmell, D. Hopkins, 2001 .

Effects of Glycemic Control on Protective Responses Against Hypoglycemia in Type 2 Diabetes

I. Macdonald, S. Amiel, K. Matyka, 1998, Diabetes Care.

Diabetes, obesity and COVID‐19: A complex interplay

F. Rubino, D. Hopkins, M. Whyte, 2020, Diabetes, obesity & metabolism.

Evidence of patient self-testing at clinic review: association with glycaemic control

Stephen Thomas, M. Whyte, D. Hopkins, 2015 .